Announced Thu, 6 Aug · 15:08 IST
SEBI initiates forensic audit of Nath Bio-Genes for FY2021 to FY2026
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.7%1-day move
₹164.04
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.7-4.2-4.3-4.9-5.4-5.2————
Up moveDown movePending
AI summary
SEBI has appointed CNK and Associates LLP as Forensic Auditor to examine Nath Bio-Genes books of account and records for FY2020-21 to FY2025-26. The company received the communication on 5 August 2026 and is extending full cooperation. The audit will look into specific matters flagged by SEBI. The company is not commenting further pending completion of the audit.
Likely market impact
SEBI forensic audit signals regulatory scrutiny; outcome may affect stock sentiment and investor confidence. Uncertainty until results are known.